Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets
- PMID: 7904306
- PMCID: PMC6576858
- DOI: 10.1523/JNEUROSCI.14-01-00088.1994
Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets
Abstract
Potential cellular substrates for functions ascribed to the dopamine D2 receptor were examined in rat brain using immunoperoxidase for localization of a D2 receptor peptide and immunogold staining for the catecholamine biosynthetic enzyme tyrosine hydroxylase (TH). Specificity of the rat polyclonal antiserum, raised against a 15 amino acid fragment from the third intracellular loop of the D2 receptor, was shown by immunoblot analysis and by selective labeling of cultured Chinese hamster ovary cells permanently transfected with the cDNA for the D2 receptor. Although the light microscopic distribution of immunolabeling for the D2 peptide was diffuse, it was selectively localized to regions containing dopamine cells (substantia nigra and ventral tegmental area) or their forebrain projections (dorsal and ventral striatum, nucleus accumbens, and olfactory tubercles). Electron microscopic examination of the medial substantia nigra and ventral tegmental area revealed readily detectable peroxidase immunoreactivity for the D2 peptide, primarily associated with the smooth endoplasmic reticulum and plasmalemmal surfaces of dendrites. Many D2 peptide-immunoreactive dendrites also contained immunogold labeling for TH, although some dendrites were singly labeled for either marker. In the medial and dorsolateral striatum, immunoperoxidase product for the D2 peptide was localized most extensively in dendrites, with the greatest intensity of immunolabeling seen in spines. A number of striatal dendrites exhibiting D2 peptide labeling were contacted by axon terminals immunoreactive for TH. Additionally, D2 peptide immunoreactivity was distributed to some synaptic vesicles and portions of the plasmalemmal surface in unmyelinated axons and in axon terminals. Most D2 peptide-immunoreactive terminals either lacked detectable membrane specializations, or formed thin, symmetric synapses in single sections. A few D2 peptide-labeled terminals formed asymmetric junctions on dendritic spines. In dually labeled sections, most D2 peptide-immunoreactive terminals lacked detectable immunolabeling for TH. However, in fortunate planes of section, peroxidase product for D2 peptide immunoreactivity was occasionally seen in pre-terminal portions of axons whose terminal varicosities contained immunogold labeling for TH. These ultrastructural results are consistent with the localization of a dopamine D2 receptor-like protein that is strategically positioned to subserve (1) autoreceptor functions at the level of dendrites in the midbrain and presynaptic axon terminals in the striatum, as well as (2) postsynaptic actions on striatal spiny dendrites and other nondopamine terminals.
Similar articles
-
Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions.J Neurosci. 1992 Apr;12(4):1335-50. doi: 10.1523/JNEUROSCI.12-04-01335.1992. J Neurosci. 1992. PMID: 1348271 Free PMC article.
-
Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.Brain Res. 1994 Jun 6;647(2):307-22. doi: 10.1016/0006-8993(94)91330-7. Brain Res. 1994. PMID: 7522922
-
Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum.Synapse. 2002 Mar 1;43(3):151-62. doi: 10.1002/syn.10033. Synapse. 2002. PMID: 11793420
-
Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron.Prog Brain Res. 2002;136:145-55. doi: 10.1016/s0079-6123(02)36014-x. Prog Brain Res. 2002. PMID: 12143378 Review.
-
Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter.J Comp Neurol. 1999 Jul 26;410(2):197-210. doi: 10.1002/(sici)1096-9861(19990726)410:2<197::aid-cne3>3.0.co;2-d. J Comp Neurol. 1999. PMID: 10414527 Review.
Cited by
-
Pathway-Specific Dopamine Abnormalities in Schizophrenia.Biol Psychiatry. 2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Epub 2016 Mar 31. Biol Psychiatry. 2017. PMID: 27206569 Free PMC article. Review.
-
Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors.Front Synaptic Neurosci. 2018 Jul 10;10:20. doi: 10.3389/fnsyn.2018.00020. eCollection 2018. Front Synaptic Neurosci. 2018. PMID: 30042672 Free PMC article. Review.
-
Dopamine alters AMPA receptor synaptic expression and subunit composition in dopamine neurons of the ventral tegmental area cultured with prefrontal cortex neurons.J Neurosci. 2007 Dec 26;27(52):14275-85. doi: 10.1523/JNEUROSCI.2925-07.2007. J Neurosci. 2007. PMID: 18160635 Free PMC article.
-
Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats.Neurochem Res. 2011 Oct;36(10):1740-9. doi: 10.1007/s11064-011-0489-z. Epub 2011 May 25. Neurochem Res. 2011. PMID: 21611835
-
Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.Neuroscience. 2013 Nov 12;252:126-43. doi: 10.1016/j.neuroscience.2013.08.008. Epub 2013 Aug 15. Neuroscience. 2013. PMID: 23954803 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources